consistency is key
Some healthcare providers may have insights into local resources or non-profit organizations that can assist with medication costs, making it essential for patients to engage in open discussions about their financial concerns with their care teams
Key takeaways Nausea is the most common side effect of Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, and the most common reason patients in trials and in clinic consider stopping
Type 1 diabetes GLP-1 RA starts are currently off license and do blend better with individual consultations rather than a group setting at this time
What are post-treatment guidelines
While retatrutide sits on the horizon, semaglutide and tirzepatide are FDA approved, available now, and backed by the phase 3 results shown above